Clinical Trial Update: Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 study assessing the safety and efficacy of enzalutamide in patients with advanced, androgen receptor-positive triple-negative breast cancer; results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)

Snippet

Sponsor: Pfizer | Conditions: Advanced, Androgen Receptor Positive Triple Negative Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-08-22